glutamine has been researched along with Autosomal Dominant Hereditary Spastic Paraplegia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burness, CE; Chinnery, PF; Cox, LE; Dalton, A; Hadjivassiliou, M; Hewamadduma, C; Kirby, J; McDermott, CJ; Rao, DG; Sharrack, B; Shaw, PJ | 1 |
| Ang, D; Bross, P; Christensen, JH; Georgopoulos, C; Gregersen, N; Hansen, J; Nielsen, JE; Nielsen, MN; Svenstrup, K | 1 |
2 other study(ies) available for glutamine and Autosomal Dominant Hereditary Spastic Paraplegia
| Article | Year |
|---|---|
Clinical features of hereditary spastic paraplegia due to spastin mutation.
Topics: Adenosine Triphosphatases; Adult; Aged; Cohort Studies; DNA Mutational Analysis; Exons; Female; Genetic Testing; Glutamine; Humans; Leucine; Male; Middle Aged; Mutation; Phenotype; Proline; Retrospective Studies; Serine; Spastic Paraplegia, Hereditary; Spastin; United Kingdom | 2006 |
A novel mutation in the HSPD1 gene in a patient with hereditary spastic paraplegia.
Topics: Aged; Chaperonin 60; Chaperonins; Denmark; Family Health; Female; Glutamic Acid; Glutamine; Humans; Male; Microtubule-Associated Proteins; Middle Aged; Mitochondrial Proteins; Mutation, Missense; Spastic Paraplegia, Hereditary | 2007 |